Our reports provide an independent, expert view supported by robust and innovative data interrogation and analysis.

Refine Sector
Sub-Category
Clear
Publish Date
Clear
Region
Clear
Clear All
Sort by:
Global Immunology Drugs Market to 2022 –Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive Growth

Published: May-2017

Immunology is a therapy area characterized by disorders of the immune system, specifically an aberrant autoimmune response.....

$4995
More Info
Rheumatoid Arthritis Therapeutics in South-East Asia Markets to 2022 – Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs

Published: Apr-2017

Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable autoimmune disease that primarily affects.....

$4995
More Info
Breast Cancer Therapeutics in Southeast Asia Markets to 2022 – Increasing Prevalence and Usage of Premium Targeted Therapies to Drive the Market

Published: Apr-2017

Breast cancer is a malignant neoplasm that begins in the breast tissue. Most breast cancers are invasive cancers that.....

$4995
More Info
Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market

Published: Mar-2017

The respiratory therapy area consists of indications that affect the respiratory system in various ways, including the.....

$4995
More Info
Global Cancer Supportive Care Therapeutics Market to 2022 – Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets

Published: Mar-2017

The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce.....

$4995
More Info
Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2023 – Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

Published: Mar-2017

Non-Small Cell Lung Cancer (NSCLC) is the most common cancer and the leading cause of cancer-related mortality globally......

$4995
More Info
COPD Therapeutics in Asia-Pacific Markets to 2022 – Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies

Published: Jan-2017

Chronic obstructive pulmonary disease (COPD) is a term that refers to a large group of lung diseases characterized by.....

$4995
More Info
Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance

Published: Jan-2017

The antibacterial drug market covers the drugs used in the prophylaxis and treatment of bacterial infections. With a growing.....

$4995
More Info
Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2022 – Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline

Published: Dec-2016

Hypertension is a serious and common medical condition characterized by elevated blood pressure......

$4995
More Info
Global Cancer Immunotherapies Market to 2022 – Immune Checkpoint Inhibitors and Therapeutic Cancer Vaccines to Characterize Increasingly Competitive Market

Published: Dec-2016

Cancer is a group of diseases characterized by abnormal cell growth. It is a multi-step process, as a single mutation.....

$4995
More Info
Sort by: